Innovation + Divide...
Health Care: Drugs
Amicus Therapeutics Inc. (FOLD: NASDAQ)
$6.79 -0.03 | -0.44%
02/08/12 - 04:00 PM ET
135.29K / 88.10K
Vol / Avg. Vol:6.85 / 6.82
Open / Prev. Close:6.69 - 6.94
Today's Range:2.10 - 8.12
52 Wk Range:97.38%
Performance YTD:TheStreet Rating:
Portfolios with FOLD
- Portfolio NameUser Type
- ContributorUnder-$10 Setting Up To Tra...
- ContributorRelative Strength Stocks 09...
- UserPART 1 JPMorgan 28th Annual...
- UserPART 1 JPMorgan 27th Annual...
- UserBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
- UserPART 1 JPMorgan 26th Annual...
- UserInsider Biotech Buys
- UserZeke1 Portfolio 1
- Userfmarct Portfolio 1
Latest FOLD Headlines from TheStreet
- 5 Stocks Under $10 Setting Up to Soar 01.13.12 | 01:01 pm
- Breakout Stocks, Teekay Offshore, Emerging Market Stars 12.14.10 | 04:12 pm
- Stock Wrap: The Real Story, December 14
12.14.10 | 04:12 pm - Amicus Therapeutics CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.08.10 | 08:11 pm
- Amicus Agreement With GSK - Call Transcript 10.31.10 | 12:10 am
- Amicus Therapeutics Agreement With GSK - Call Transcript 10.31.10 | 12:10 am
- Amicus Therapeutics, Inc. Q2 2010 Earnings Call Transcript 08.05.10 | 11:08 pm
- Amicus Therapeutics, Inc. Q1 2010 Earnings Call Transcript 05.07.10 | 01:05 am
- China Information Security, EF Johnson: Early Volume Plays 04.06.10 | 07:04 am
- Movers Roundup: Las Vegas Sands, Monster 10.30.09 | 02:10 pm
Press Releases for FOLD
- Amicus Therapeutics Joins Russell 3000® Index - PR Newswire 06.27.11 | 09:06 am
- Amicus Therapeutics To Present At Jefferies 2011 Global Healthcare Conference On Tuesday, June 7, 2011 - PR Newswire 05.31.11 | 09:05 am
- Amicus Therapeutics Announces Transition Of John F. Crowley From Chairman And Chief Executive Officer To Executive Chairman - PR Newswire 04.18.11 | 04:04 pm
- Amicus Therapeutics To Present At The 13th Annual BIO CEO And Investor Conference On Tuesday, February 15, 2011 - PR Newswire 02.10.11 | 08:02 am
- Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal⢠Co-administered With Enzyme Replacement Therapy - PR Newswire 02.09.11 | 07:02 am
- Amicus Therapeutics To Host Its Third Quarter 2010 Financial Results Conference Call And Webcast On November 8, 2010 - PR Newswire 11.02.10 | 08:11 am
- Amicus Therapeutics To Host Conference Call And Webcast To Discuss Exclusive Worldwide Agreement With GSK To Develop And Commercialize Amigal⢠For Fabry Disease - PR Newswire 10.29.10 | 06:10 am
- Amicus Therapeutics To Present At The BIO Investor Forum On October 5, 2010 - PR Newswire 09.30.10 | 08:09 am
- Amicus Therapeutics To Present At The Canaccord Genuity 30th Annual Growth Conference On August 12, 2010 - PR Newswire 08.04.10 | 08:08 am
- Amicus Therapeutics To Host Its Second Quarter 2010 Financial Results Conference Call And Webcast On August 5, 2010 - PR Newswire 07.27.10 | 08:07 am
Partner Headlines for FOLD
- ETF Deathwatch For September 2011: Ben Graham Has Left The Building - Seeking Alpha 09.12.11 | 09:09 am
- J.P. Morgan Maintains Neutral on Amicus Therapeutics (FOLD) - Benzinga 04.19.11 | 09:04 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.02.10 | 09:11 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.06.10 | 09:10 am
- FDA, Clinical Trial Binary Events: Amarin, Amicus, Labopharm - Seeking Alpha 08.08.10 | 08:08 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 05.06.10 | 09:05 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 04.29.10 | 09:04 am
